The future of Cell & Gene Therapy (CGT) is automated. But how do we bridge the gap between complex manual processes and scalable, efficient production?
Our CEO, Fabian Stutz, will be speaking on behalf of at the GENAP Summit in Vienna (May 5–6, 2026). This premier event focuses on the real-world challenges of aseptic processing and ATMP manufacturing.
- 🎤 Presentation: “State of the Art Robotics in CGT – Challenges and Opportunities”
- 🕒 When: May 5, 2026 | 14:30
- 🔗 Registration & Program: https://genapsummit.com/
𝐖𝐡𝐚𝐭 𝐰𝐞 𝐰𝐢𝐥𝐥 𝐞𝐱𝐩𝐥𝐨𝐫𝐞:
- ➡️ 𝐓𝐡𝐞 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫: Why robotics is the key to handling the inherent complexity of Cell & Gene Therapies.
- ➡️𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐚𝐭 𝐒𝐜𝐚𝐥𝐞: Strategies to automate CGT processes effectively without compromising on the highest quality standards.
- ➡️𝐋𝐚𝐭𝐞𝐬𝐭 𝐓𝐫𝐞𝐧𝐝𝐬: A deep dive into current technological possibilities that are transforming the manufacturing landscape.
We look forward to sharing how Pharmabotix is driving this change through #innovative #robotic #solutions and discussing the evolving regulatory landscape with fellow industry experts.
